OMEROS CORP Contracts & Agreements

197 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Pledge and Security Agreement, dated as of June 3, 2024, between the Company, nura inc. and Wilmington Savings Fund Society, FSB, as Collateral Agent
OMEROS CORP
2024
Sixteenth Amendment to Lease dated July 8, 2024 between Omeros Corporation and BMR-201 Elliott Avenue LLC
Lease Agreements
OMEROS CORP
2024
Fifteenth Amendment to Lease dated November 1, 2022 between Omeros Corporation and BMR-201 Elliott Avenue LLC
Lease Agreements
OMEROS CORP
2024
Credit and Guaranty Agreement, dated as of June 3, 2024, among the Company, certain subsidiaries of the Company, as guarantors, various Lenders and Wilmington Savings Fund...
OMEROS CORP
2024
License Agreement between Omeros Corporation and Daiichi Sankyo Co., Ltd. (successor-in-interest to Asubio Pharma Co., Ltd.) dated March 3, 2010
License Agreements
OMEROS CORP
2024
Amendment No. 1 to License Agreement with an effective date of January 5, 2011 between Omeros Corporation and Daiichi Sankyo Co., Ltd
License Agreements
OMEROS CORP
2024
Amendment No. 2 to License Agreement with an effective date of January 25, 2013 between Omeros Corporation and Daiichi Sankyo Co., Ltd
License Agreements
OMEROS CORP
2024
Amended and Restated Royalty Purchase Agreement between Omeros Corporation and DRI Healthcare Acquisitions LP dated February 1, 2024
Purchase Agreements
OMEROS CORP
2024
Technology License Agreement, effective August 28, 2020 between Omeros Corporation and Xencor, Inc
License Agreements
OMEROS CORP
2023
Omeros Corporation Non-Employee Director Compensation Policy
Compensation Agreements
OMEROS CORP
2023
Royalty Purchase Agreement dated September 30, 2022 between Omeros Corporation and DRI Healthcare Acquisitions LP
Purchase Agreements
OMEROS CORP
2022
Fourteenth Amendment to Lease dated January 14, 2022 between Omeros Corporation and BMR-201 Elliott Avenue LLC
Lease Agreements
OMEROS CORP
Pharmaceuticals
2022
Asset Purchase Agreement, dated as of December 1, 2021 among Omeros Corporation, Rayner Surgical Inc. and Rayner Surgical Group, Limited, as Parent Guarantor
Purchase Agreements
OMEROS CORP
2022
Consent and Second Amendment to Loan and Security Agreement, dated as of December 1, 2021, by and between Omeros Corporation and Silicon Valley Bank
Loan Agreements
OMEROS CORP
Pharmaceuticals
2022
Master Service Agreement dated July 28, 2019, as amended, between Omeros Corporation and Lonza Biologics Tuas Pte Ltd
Services Agreements
OMEROS CORP
Pharmaceuticals
NY
2021
Thirteenth Amendment to Lease dated June 1, 2021 between Omeros Corporation and BMR-201 Elliott Avenue LLC
Lease Agreements
OMEROS CORP
2021
Omeros Corporation 2017 Omnibus Incentive Compensation Plan (as amended and restated effective June 11, 2021)
Bonus & Incentive Agreements
OMEROS CORP
2021
Sales Agreement, dated March 1, 2021, between Omeros Corporation and Cantor Fitzgerald & Co
Sales Agreements
OMEROS CORP
2021
Description of Common Stock
Stock Agreements
OMEROS CORP
2021
Omeros Corporation Non-Employee Director Compensation Policy
Compensation Agreements
OMEROS CORP
Pharmaceuticals
2021
Eleventh Amendment to Lease dated October 23, 2020 between Omeros Corporation and BMR-201 Elliott Avenue LLC
Lease Agreements
OMEROS CORP
2021
Twelfth Amendment to Lease dated January 1, 2021 between Omeros Corporation and BMR-201 Elliott Avenue LLC
Lease Agreements
OMEROS CORP
2021
Tenth Amendment to Lease Agreement, dated September 15, 2020, by and between Omeros Corporation and BMR-201 Elliott Avenue LLC
Lease Agreements
OMEROS CORP
2020
Underwriting Agreement, dated as of August 11, 2020, between Omeros Corporation and BofA Securities, Inc. and J.P. Morgan Securities LLC, as representatives of the Equity...
Underwriting Agreements
OMEROS CORP
2020
Underwriting Agreement, dated as of August 11, 2020, between Omeros Corporation and BofA Securities, Inc. and J.P. Morgan Securities LLC, as representatives of the Notes...
Underwriting Agreements
OMEROS CORP
Pharmaceuticals
NY
2020
Indenture, dated as of August 14, 2020, between Omeros Corporation and Wells Fargo Bank, National Association, as trustee
Indenture Agreements
OMEROS CORP
2020
First Supplemental Indenture, dated as of August 14, 2020, between Omeros Corporation and Wells Fargo Bank, National Association, as trustee
Indenture Agreements
OMEROS CORP
2020
Form of Capped Call Transaction Confirmation
OMEROS CORP
Pharmaceuticals
NY
2020
First Amendment to Loan and Security Agreement, dated as of August 7, 2020, by and between Omeros Corporation and Silicon Valley Bank
Loan Agreements
OMEROS CORP
Pharmaceuticals
2020
Ninth Amendment to Lease dated January 15, 2020 between Omeros Corporation and BMR-201 Elliott Avenue LLC
Lease Agreements
OMEROS CORP
2020
Consulting Agreement effective February 10, 2020 between Omeros Corporation and Kurt Zumwalt
Consulting Agreements
OMEROS CORP
2020
Description of Common Stock
Stock Agreements
OMEROS CORP
Pharmaceuticals
2020
Eighth Amendment to Lease dated October 18, 2019 between Omeros Corporation and BMR-201 Elliott Avenue LLC
Lease Agreements
OMEROS CORP
2020
Underwriting Agreement, dated December 5, 2019, between Omeros Corporation and Cantor Fitzgerald & Co
Underwriting Agreements
OMEROS CORP
Pharmaceuticals
NY
2019
Master Services Agreement, dated July 28, 2019, between Omeros Corporation and Lonza Biologics Tuas Pte. Ltd
Services Agreements
OMEROS CORP
Pharmaceuticals
NY
2019
Seventh Amendment to Lease, dated April 15, 2019, between Omeros Corporation and BMR-201 Elliott Avenue LLC
Lease Agreements
OMEROS CORP
2019
Loan and Security Agreement by and between Omeros Corporation and Silicon Valley Bank, dated August 2, 2019
Loan Agreements
OMEROS CORP
Pharmaceuticals
WA
2019
OMEROS CORPORATION 2017 Omnibus Incentive Compensation Plan (as amended and restated effective as of June 7, 2019)
Bonus & Incentive Agreements
OMEROS CORP
Pharmaceuticals
WA
2019
Sixth Amendment to Lease dated October 18, 2018 between Omeros Corporation and BMR-201 Elliott Avenue LLC
Lease Agreements
OMEROS CORP
2019
Indenture, dated as of November 15, 2018, between Omeros Corporation and Wells Fargo Bank, National Association, as trustee (including the form of 6.25% Convertible Senior Notes...
Indenture Agreements
OMEROS CORP
Pharmaceuticals
WA
2018
Purchase Agreement, dated November 8, 2018, among Omeros Corporation and Cantor Fitzgerald & Co. and UBS Securities LLC as the initial purchasers, relating to the Companys 6.25%...
Note Agreements
OMEROS CORP
Pharmaceuticals
NY
2018
Form of capped call transaction confirmation, dated as of November 8, 2018, by and between Royal Bank of Canada and Omeros Corporation, in reference to the 6.25% Convertible...
Note Agreements
OMEROS CORP
2018
Settlement Agreement, dated as of May 22, 2018, by and among Omeros Corporation and Lupin Ltd. and Lupin Pharmaceuticals, Inc
Settlement Agreements
OMEROS CORP
2018
Third Amendment to Term Loan Agreement among Omeros Corporation, nura, inc., CRG Servicing LLC, as administrative agent and collateral agent, and certain lenders thereto, dated...
Loan Agreements
OMEROS CORP
Pharmaceuticals
TX
2018
Form of Warrant to Purchase Stock issued by Omeros Corporation to each lender
Warrant Agreements
OMEROS CORP
Pharmaceuticals
TX
2018
Amendment No. 2 to Loan Agreement among Omeros Corporation, CRG Servicing LLC, as administrative agent and collateral agent, and the lenders named therein, dated February 26, 2018
Loan Agreements
OMEROS CORP
2018
Amendment No. 1 to Loan Agreement between among Omeros Corporation, CRG Servicing LLC, as administrative agent and collateral agent, and the lenders named therein, dated October...
Loan Agreements
OMEROS CORP
Pharmaceuticals
TX
2017
Settlement Agreement, dated October 4, 2017, by and among Omeros Corporation, Par Sterile Products, LLC and Par Pharmaceutical, Inc
Settlement Agreements
OMEROS CORP
2017
Underwriting Agreement, dated August 14, 2017, among Omeros Corporation and Cantor Fitzgerald & Co., as representative of the Underwriters
Underwriting Agreements
OMEROS CORP
2017
Omeros Corporation Non-Employee Director Compensation Policy
Compensation Agreements
OMEROS CORP
Pharmaceuticals
2017
FIFTH AMENDMENT TO LEASE
Lease Agreements
OMEROS CORP
Pharmaceuticals
2017
OMEROS CORPORATION 2008 EQUITY INCENTIVE PLAN (as amended December 13, 2016)
Bonus & Incentive Agreements
OMEROS CORP
Pharmaceuticals
WA
2017
OMEROS CORPORATION NON-EMPLOYEE DIRECTOR COMPENSATION POLICY
Compensation Agreements
OMEROS CORP
2017
Third Amendment to Pharmaceutical Manufacturing and Supply Agreement
Supply Agreements
OMEROS CORP
2017
Second Amendment to Pharmaceutical Manufacturing and Supply Agreement
Supply Agreements
OMEROS CORP
Pharmaceuticals
2016
TERM LOAN AGREEMENT dated as of October 26, 2016 among OMEROSCORPORATION, as Borrower, The Subsidiary Guarantors from Time to Time Party Hereto, The Lenders from Time to Time...
Loan Agreements
OMEROS CORP
2016
SECURITY AGREEMENT dated as of October[], 2016 among OMEROS CORPORATION, The Other Grantors from Time to Time Party Hereto and CRG SERVICING LLC, as Administrative Agent and...
Security Agreements
OMEROS CORP
2016
OMEROS CORPORATION 3,478,260 Shares of Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
OMEROS CORP
2016
FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT
Loan Agreements
OMEROS CORP
Pharmaceuticals
2016
FORM OF WARRANT TO PURCHASE STOCK
Warrant Agreements
OMEROS CORP
2016
PROJECT AGREEMENT (SALES OPERATIONS SERVICES for CLIENT SALES TEAMS)
Sales Agreements
OMEROS CORP
Pharmaceuticals
2016
OMEROSCORPORATION Common Stock (par value $0.01 per share) AtMarket Issuance Sales Agreement
Stock Agreements
OMEROS CORP
Pharmaceuticals
NY
2016
LOAN AND SECURITY AGREEMENT
Loan Agreements
OMEROS CORP
Pharmaceuticals
CA
2016
FIRST AMENDMENT TO COMMERCIAL SUPPLY AGREEMENT
Supply Agreements
OMEROS CORP
Pharmaceuticals
2015
First Amendment to Pharmaceutical Manufacturing and Supply Agreement
Supply Agreements
OMEROS CORP
2015
FOURTH AMENDMENT TO LEASE
Lease Agreements
OMEROS CORP
2015
LICENSE AGREEMENT
License Agreements
OMEROS CORP
2015
RESEARCH AND DEVELOPMENT AGREEMENT EIGHTH AMENDMENT
Development Agreements
OMEROS CORP
Pharmaceuticals
2015
FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT
Loan Agreements
OMEROS CORP
2015
SECOND AMENDMENT TO PROJECT AGREEMENT (Detailing and Sales Operations Services)
Sales Agreements
OMEROS CORP
2015
COMMERCIAL SUPPLY AGREEMENT
Supply Agreements
OMEROS CORP
Pharmaceuticals
WA
2015
OMEROSCORPORATION 2,995,506 Shares of Common Stock and Pre-Funded Warrants to Purchase 749,250 Shares of Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
OMEROS CORP
Pharmaceuticals
NY
2015
NOTICE OF WARRANT EXTENSION September 28, 2014
Warrant Agreements
OMEROS CORP
Pharmaceuticals
2014
MASTER SERVICE AGREEMENT
Services Agreements
OMEROS CORP
Pharmaceuticals
NY
2014
PROJECT AGREEMENT (DETAILING AND SALES OPERATION SERVICES)
Sales Agreements
OMEROS CORP
2014
FIRST AMENDMENT TO PROJECT AGREEMENT (Detailing and Sales Operations Services)
Sales Agreements
OMEROS CORP
2014
TABLE OF CONTENTS
OMEROS CORP
2014
NOTICE OF WARRANT EXTENSION March 28, 2014
Warrant Agreements
OMEROS CORP
2014
3,043,479 OMEROSCORPORATION Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
OMEROS CORP
Pharmaceuticals
NY
2014
THIRD AMENDMENT TO LEASE
Lease Agreements
OMEROS CORP
2014
SETTLEMENT AGREEMENT AND RELEASE
Settlement Agreements
OMEROS CORP
Pharmaceuticals
2014
EIGHTH AMENDMENT TO LOAN AND SECURITY AGREEMENT
Loan Agreements
OMEROS CORP
2014
LOAN AND SECURITY AGREEMENT
Loan Agreements
OMEROS CORP
2014
OMEROS CORPORATION 2008 EQUITY INCENTIVE PLAN NOTICE OF GRANT OF STOCK OPTION
Bonus & Incentive Agreements
OMEROS CORP
2013
OMEROS CORPORATION SUBSCRIPTION AGREEMENT
Subscription Agreements
OMEROS CORP
2013
Amendment No. 2 to LICENSE AGREEMENT
License Agreements
OMEROS CORP
2013
NOTICE OF WARRANT EXTENSION March 28, 2013
Warrant Agreements
OMEROS CORP
2013
SECOND AMENDMENT TO LEASE
Lease Agreements
OMEROS CORP
2013
FIRST AMENDMENT TO PATENT ASSIGNMENT AGREEMENT
Assignment Agreements
OMEROS CORP
2013
Amendment No. 2 to LICENSE AGREEMENT
License Agreements
OMEROS CORP
Pharmaceuticals
2013
CONSENT AND FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT
Loan Agreements
OMEROS CORP
Pharmaceuticals
2013
THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT
Loan Agreements
OMEROS CORP
Pharmaceuticals
2013
FOURTH AMENDMENT TO LOAN AND SECURITY AGREEMENT
Loan Agreements
OMEROS CORP
2013
FIFTH AMENDMENT TO LOAN AND SECURITY AGREEMENT
Loan Agreements
OMEROS CORP
2013
SIXTH AMENDMENT TO LOAN AND SECURITY AGREEMENT
Loan Agreements
OMEROS CORP
Pharmaceuticals
2013
SECURED PROMISSORY NOTE (Tranche 3 Advance)
Note Agreements
OMEROS CORP
Pharmaceuticals
2013
SECURED PROMISSORY NOTE (Tranche 3 Advance)
Note Agreements
OMEROS CORP
2013
ALLONGE TO SECURED PROMISSORY NOTE (CLOSING DATE ADVANCE)
Note Agreements
OMEROS CORP
2013
ALLONGE TO SECURED PROMISSORY NOTE (TRANCHE 2 ADVANCE)
Note Agreements
OMEROS CORP
Pharmaceuticals
2013
OMEROS CORPORATION Common Stock (par value $0.01 per share) At Market Issuance Sales Agreement
Stock Agreements
OMEROS CORP
Pharmaceuticals
NY
2012
FIRST AMENDMENT TO LEASE
Lease Agreements
OMEROS CORP
2012
AMENDED AND RESTATED SETTLEMENT AGREEMENT AND RELEASE
Settlement Agreements
OMEROS CORP
2012
FOURTH AMENDMENT TO OFFICE LEASE AGREEMENT
Lease Agreements
OMEROS CORP
Pharmaceuticals
2012
2,926,830 OMEROS CORPORATION Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
OMEROS CORP
2012
NOTICE OF WARRANT EXTENSION March 28, 2012
Warrant Agreements
OMEROS CORP
2012
LEASE by and between BMR-201 ELLIOTT AVENUE LLC, a Delaware limited liability company and OMEROS CORPORATION, a Washington corporation LEASE
Lease Agreements
OMEROS CORP
Pharmaceuticals
CA
2012
Amendment No. 1 to LICENSE AGREEMENT
License Agreements
OMEROS CORP
2011
COMMON STOCK PURCHASE AGREEMENT Dated as of May 10, 2011 by and between OMEROS CORPORATION and AZIMUTH OPPORTUNITY LTD. TABLE OF CONTENTS
Stock Agreements
OMEROS CORP
Pharmaceuticals
WA
2011
30 SunnysideAvenue | Mill Valley | CA 94941 | (415) 383-4700 | Fax ###-###-####
OMEROS CORP
Pharmaceuticals
CA
2011
SECURED PROMISSORY NOTE (TRANCHE 2 ADVANCE)
Note Agreements
OMEROS CORP
Pharmaceuticals
2011
SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT
Loan Agreements
OMEROS CORP
2011
PLATFORM DEVELOPMENT FUNDING AGREEMENT Dated as of October 21, 2010 among OMEROS CORPORATION, VULCAN INC. and COUGAR INVESTMENT HOLDINGS LLC
Development Agreements
OMEROS CORP
2011
Life Sciences Discovery Fund LSDF 10-05 Opportunity Grant Grant Award Agreement
OMEROS CORP
Pharmaceuticals
WA
2011
LOAN AND SECURITY AGREEMENT
Loan Agreements
OMEROS CORP
2010
SECURED PROMISSORY NOTE (CLOSING DATE ADVANCE)
Note Agreements
OMEROS CORP
2010
OMEROS CORPORATION Common Stock Purchase Warrant
Warrant Agreements
OMEROS CORP
2010
Current assets
OMEROS CORP
Pharmaceuticals
DE
2010
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
OMEROS CORP
Pharmaceuticals
NY
2010
COMMON STOCK PURCHASE AGREEMENT
Stock Agreements
OMEROS CORP
2010
30 Sunnyside Avenue | Mill Valley | CA 94941 | (415) 383-4700 | Fax ###-###-####
OMEROS CORP
2010
Current assets
OMEROS CORP
Pharmaceuticals
NY
2010
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
OMEROS CORP
2010
FIRST AMENDMENT
OMEROS CORP
2010
FIRST AMENDMENT OF EXCLUSIVE TECHNOLOGY OPTION AGREEMENT
OMEROS CORP
Pharmaceuticals
2009
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
Pharmaceuticals
2009
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2009
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
Pharmaceuticals
WA
2009
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
Pharmaceuticals
2009
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
Pharmaceuticals
DE
2009
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
Pharmaceuticals
2009
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2009
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
Pharmaceuticals
2009
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2009
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2009
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2009
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2009
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
Pharmaceuticals
2009
COMMERCIAL SUPPLY AGREEMENT
Supply Agreements
OMEROS CORP
Pharmaceuticals
DE
2009
EXCLUSIVE LICENSE AND SPONSORED RESEARCH AGREEMENT
License Agreements
OMEROS CORP
Pharmaceuticals
2009
EXCLUSIVE LICENSE AND SPONSORED RESEARCH AGREEMENT between OMEROS CORPORATION and MEDICAL RESEARCH COUNCIL
License Agreements
OMEROS CORP
Pharmaceuticals
DE
2009
FUNDING AGREEMENT
Funding Agreements
OMEROS CORP
2009
DATED 20 April 2007
OMEROS CORP
2009
AMENDMENT dated 30 April 2007 of the SERVICES AND MATERIALS AGREEMENT dated 20 April 2007 By and between SCOTTISH BIOMEDICAL LIMITED T/A SCOTTISH BIOMEDICAL and OMEROS CORPORATION
Services Agreements
OMEROS CORP
2009
Drug Product Development and Clinical Supply Agreement
Development Agreements
OMEROS CORP
Pharmaceuticals
CA
2009
MASTER SERVICES AGREEMENT
Services Agreements
OMEROS CORP
2009
AGREEMENT FOR ANTIBODY DISCOVERY AND DEVELOPMENT
Development Agreements
OMEROS CORP
Pharmaceuticals
CA
2009
EXCLUSIVE TECHNOLOGY OPTION AGREEMENT
OMEROS CORP
Pharmaceuticals
WA
2009
LOAN AND SECURITY AGREEMENT No. V08302
Loan Agreements
OMEROS CORP
2009
PROMISSORY NOTE Dated: September 12, 2008 Chicago, Illinois
Note Agreements
OMEROS CORP
2009
PROMISSORY NOTE Dated: December 23, 2008 Chicago, Illinois
Note Agreements
OMEROS CORP
2009
OMEROS CORPORATION
OMEROS CORP
Pharmaceuticals
WA
2009
PATENT ASSIGNMENT AGREEMENT
Assignment Agreements
OMEROS CORP
Pharmaceuticals
2009
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2009
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2008
obtain regulatory approval for our PharmacoSurgery product candidates OMS103HP, OMS302 and OMS201
OMEROS CORP
2008